X4 Pharmaceuticals, Inc (XFOR) has 18 open-market insider trades by 10 insiders since 2020. Over the last six months insiders net sold $463K. The most active filer is Paula Ragan, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Adam R. Craig | Chairman | — | 2 | $711K | 2026-08-12 |
| Paula Ragan | CEOPres | — | 5 | $435K | 2025-02-12 |
| Murray Stewart | — | — | 1 | $276K | 2025-06-09 |
| Adam S. Mostafa | CFO | — | 3 | $259K | 2025-02-12 |
| David Kirske | CFO | — | 2 | $109K | 2026-06-30 |
| John Volpone | Pres | — | 1 | $109K | 2026-08-12 |
| Derek M. Meisner | CLO | — | 1 | $67K | 2022-03-01 |
| David Kirske | CFO | — | 1 | $34K | 2026-10-01 |
| Michael S. Wyzga | Dir | — | 1 | $30K | 2025-06-09 |
| Mark Baldry | Chief Commercial Officer | — | 1 | $19K | 2025-05-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Kirske | CFO | Sell | $34K | 2026-10-01 |
| John Volpone | President | Sell | $109K | 2026-08-12 |
| Adam R. Craig | Chairman | Sell | $211K | 2026-08-12 |
| David Kirske | CFO | Sell | $36K | 2026-06-30 |
| David Kirske | CFO | Sell | $73K | 2026-05-12 |
| Adam R. Craig | Chairman | Buy | $500K | 2025-10-23 |
Companies that share insiders with XFOR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark Baldry | Chief Commercial Officer | Sell | $13K | 2025-01-24 |
| Christophe Arbet-Engels | Chief Medical Officer | Sell | $5K | 2025-01-24 |
| Adam S. Mostafa | CFO | Sell | $34K | 2025-01-24 |
| Mary DiBiase | COO | Sell | $10K | 2025-01-24 |
| Paula Ragan | President | Sell | $34K | 2025-01-24 |
| Paula Ragan | President | Sell | $12K | 2024-11-15 |
| Paula Ragan | President | Sell | $18K | 2024-10-15 |
| Mark Baldry | Chief Commercial Officer | Sell | $6K | 2024-10-07 |
| Paula Ragan | CEO & President | Sell | $263K | 2024-10-07 |